查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2017994

細胞分離與細胞分級市場：2026-2032年全球市場預測（按產品、技術、細胞類型、應用和最終用戶分類）

Cell Isolation/Cell Separation Market by Product, Technology, Cell Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，細胞分離和分選市場價值將達到 63.4 億美元，到 2026 年將成長至 69.7 億美元，到 2032 年將達到 135.1 億美元，複合年成長率為 11.39%。

主要市場統計數據
基準年 2025 63.4億美元
預計年份：2026年 69.7億美元
預測年份 2032 135.1億美元
複合年成長率 (%) 11.39%

簡要概述關鍵細胞分離技術、不斷變化的終端用戶優先事項以及影響轉化研究和臨床管線的戰略考慮因素。

細胞分離和分選技術是生命科學研究和臨床應用的基石，涵蓋從基礎免疫學研究到先進細胞療法的開發等許多領域。儀器和試劑的進步正逐步降低單細胞和批量細胞精確處理的門檻，從而實現高度可重複的工作流程，並加速轉化研究進程。隨著學術團隊、生物技術創新者和臨床檢查室對可擴展且易於自動化的解決方案的需求日益成長，現有工具的種類也日益豐富，以滿足包括處理能力、純度和細胞活力在內的各種需求。

技術融合、自動化和數據驅動的工作流程如何重新定義細胞分離實踐，並改變供應商和最終用戶之間的關係。

細胞分離領域經歷了變革性的轉變，這既得益於技術的融合，也得益於不斷演變的應用需求。最初，改進的重點在於透過改進試劑和提高流式細胞技術儀的靈敏度來提升細胞純度和回收率。近年來，最顯著的變化來自於自動化樣品處理和計算分析的融合，二者的結合使得許多實驗室能夠以前所未有的規模實現可重複的細胞分離處理。

本研究評估了 2025 年美國關稅調整將如何影響整個細胞分離生態系統的採購、供應鏈策略以及製造商的採購決策。

美國近期宣布的2025年關稅調整方案引入了新的變數，影響細胞分離領域的籌資策略、供應鏈韌性和跨境合作。關稅變動會產生連鎖反應。設備和特殊試劑進口關稅的提高推高了整體成本，迫使實驗室採購團隊重新評估採購時機、供應商選擇和庫存策略。因此，各機構不得不權衡短期成本壓力與長期營運風險，後者可能源自於更換供應商或採用尚未在其工作流程中充分檢驗的替代技術。

我們透過提供基於全面細分的見解來支援採購和開發決策，這些細分將產品類型、底層技術、電池類型和最終用戶優先順序連結起來。

要了解市場動態，需要清楚掌握多個細分維度，並理解每個類別對買家和開發者的實際影響。從產品角度來看，相關人員區分耗材、儀器、試劑盒、軟體和服務。在耗材方面，一次性產品和試劑決定了每次使用的成本效益和檢測的一致性，而資料分析軟體和維護服務則影響生命週期觀點和運作。從產品轉向技術，離心和過濾等技術仍然是高通量分離的基礎，而流式細胞技術、磁珠和微流體技術則支援高解析度、標靶應用。流式細胞技術本身可進一步分為分析型細胞儀和分選型細胞儀，磁珠技術的規模從宏觀磁珠到奈米磁珠不等，每種磁珠在結合率和細胞回收率方面都存在權衡。

影響美洲、歐洲、中東和非洲以及亞太地區採用速度、供應商策略和監管協調的區域趨勢和基礎設施因素。

區域趨勢對技術應用、供應商策略和監管要求各不相同。在美洲，轉化研究的投資和細胞治療製造地的擴張推動了對符合GMP標準的設備、經過驗證的耗材以及支援規模化生產的可靠服務模式的需求。同時，歐洲、中東和非洲（EMEA）地區呈現多元化的格局，成熟的研究中心與新興的臨床市場並存。在這裡，細微的監管差異和報銷途徑會影響技術的採用進度，而與當地經銷商的合作往往決定著市場准入和支援品質。

競爭定位、平台整合和不斷發展的服務模式如何塑造供應商策略，並在細胞分離領域創造差異化的價值提案。

供應商之間的競爭日益體現在產品創新、平台整合和商業性夥伴關係模式的整合。主要企業正透過將儀器與專有耗材和軟體分析功能相結合來擴展產品組合，以確保長期永續的收入並提升用戶體驗。此外，儀器供應商與軟體開發商之間的策略合作正在加速端到端的工作流程，縮短從樣本到分析結果的週期。同時，專業供應商繼續透過諸如幹細胞微創分離技術和腫瘤應用高速分選儀等細分產品來保持差異化優勢，即使在平台整合日益普及的背景下，他們仍然為特定領域的創新留有空間。

為領導企業提供切實可行的路線圖，以增強供應鏈韌性，加速成熟技術的採用，並建立可擴展的細胞分離工作流程的資料互通性。

產業領導者應採取組合策略，平衡短期業務永續營運和長期創新投資。首先，應優先考慮從多個供應商採購，並建立緩衝庫存，以減輕關稅造成的供應鏈中斷和成本波動，同時協商確保批次可追溯性和品質保證的合約條款。其次，應投資於可互通的資料平台和經過驗證的分析工具，以實現供應商之間的整合，並將隔離結果快速轉化為下游的檢驗和製造流程。此類投資可減少協作研究中的摩擦，並支持分散式團隊獲得可重複的結果。

透過整合相關人員訪談、技術文獻綜述和交叉檢驗，我們透過高度透明的多來源調查方法得出可操作和合法的研究結果。

本分析的調查方法結合了多種證據來源，以得出穩健且可重複的結論。主要證據來源包括對研究主任、採購負責人、設備工程師和臨床營運經理的結構化訪談，旨在了解目前研究和臨床環境中的實踐和應用促進因素。二級資訊來源包括官方監管文件、同行評審文獻和製造商的技術規範，用於檢驗性能聲明並了解監管限制和驗證要求。透過整合這些資訊來源，我們識別出了主題趨勢、技術轉折點以及最終用戶使用的可操作決策標準。

總之，趨勢的整合強調互通性、供應彈性和人力資源準備是實現擴充性和可重複的細胞分離結果的關鍵要素。

總而言之，細胞分離和分選技術在技術成熟、服務導向經營模式以及區域多元化部署路徑的共同作用下不斷發展。關鍵趨勢包括向資料整合工作流程的轉變、針對脆弱細胞類型的微創分離技術的日趨成熟，以及在關稅和物流壓力下，彈性供應鏈的重要性日益凸顯。這些因素共同重塑了採購標準，終端使用者如今不僅重視設備本身的效能，也同樣重視生命週期服務、軟體互通性和法規遵循。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 細胞分離與細胞分級市場：依產品分類

  • 消耗品
    • 一次性產品
    • 試劑
  • 裝置
  • 成套工具
  • 軟體和服務
    • 數據分析軟體
    • 維護服務

第9章：細胞分離與細胞分級市場：依技術分類

  • 離心分離
  • 過濾
  • 流式細胞技術
    • 流式細胞儀分析
    • 分選細胞計數法
  • 磁珠
    • 大珠
    • 奈米珠
  • 微流體技術

第10章：依細胞類型分類的細胞分離與細胞分級市場

  • B細胞
  • 癌細胞
  • 樹突狀細胞
  • 幹細胞
  • T細胞

第11章：細胞分離與細胞分級市場：依應用領域分類

  • 細胞療法
  • 免疫學
  • 感染疾病
  • 腫瘤學
  • 產前檢查
  • 幹細胞研究

第12章：細胞分離與細胞分級市場：依最終用戶分類

  • 學術研究機構
  • 生物技術和製藥公司
  • 合約研究機構
  • 醫院和診所

第13章：細胞分離與細胞分級市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：細胞分離與細胞分級市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 細胞分離與細胞分級市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國細胞分離與細胞分級市場

第17章：中國細胞分離與細胞分級市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Agilent Technologies, Inc
  • Agilent Technologies, Inc.
  • Beckman Coulter, Inc
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc
  • Corning Incorporated
  • Danaher Corporation
  • GE Healthcare
  • Lonza Group AG
  • Merck KGaA
  • Sartorius AG
  • Terumo Corporation
  • Thermo Fisher Scientific Inc
Product Code: MRR-034230D3E62F

The Cell Isolation/Cell Separation Market was valued at USD 6.34 billion in 2025 and is projected to grow to USD 6.97 billion in 2026, with a CAGR of 11.39%, reaching USD 13.51 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 6.34 billion
Estimated Year [2026] USD 6.97 billion
Forecast Year [2032] USD 13.51 billion
CAGR (%) 11.39%

A concise orientation to core cell isolation technologies, evolving end-user priorities, and the strategic considerations shaping translational research and clinical pipelines

Cell isolation and separation technologies underpin a broad spectrum of life sciences research and clinical applications, from basic immunology studies to advanced cell therapy manufacturing. Advances in instrumentation and reagents have progressively lowered barriers to precise single-cell and bulk-cell processing, enabling more reproducible workflows and accelerating translational pathways. As academic groups, biotech innovators, and clinical laboratories increasingly demand scalable and automation-friendly solutions, the landscape of available tools has diversified to meet divergent throughput, purity, and viability requirements.

In consequence, stakeholders must evaluate technologies not only for analytical performance but also for their integration into data pipelines, regulatory compliance frameworks, and downstream processing. The convergence of microfluidics, magnetic separation, and high-resolution flow cytometry with cloud-enabled data analysis is reshaping how teams design experiments and scale processes. This introduction frames the subsequent sections by highlighting core technological drivers, evolving end-user needs, and the strategic considerations that inform procurement and development choices across research, clinical, and commercial settings.

How technological convergence, automation, and data-enabled workflows are redefining cell isolation practices and reshaping supplier and end-user dynamics

The landscape of cell isolation has experienced transformative shifts driven by both technology convergence and evolving application demands. Initially, improvements centered on enhancing cell purity and recovery through refined reagents and more sensitive cytometric instrumentation. More recently, the most consequential changes have arisen from the integration of automated sample handling and computational analysis, which together enable reproducible processing at scales previously unattainable for many laboratories.

Moreover, the development of gentle separation modalities - including nanomaterial-enhanced magnetic beads and microfluidic platforms designed to preserve cell phenotype - has opened new possibilities for delicate cell types such as stem cells and primary immune populations. As a result, workflows that once required specialist expertise are becoming accessible to a broader set of end users. Simultaneously, competitive dynamics have pushed providers to bundle consumables with service models and software, creating ecosystems that accelerate adoption but also raise considerations around vendor lock-in and data interoperability. These shifts are leading laboratories and companies to reassess procurement criteria with greater emphasis on operational continuity, data integrity, and the ability to translate isolated-cell outputs into downstream assays and therapies.

Assessing how 2025 United States tariff adjustments are altering procurement, supply chain strategies, and manufacturer sourcing decisions across the cell separation ecosystem

Recent tariff changes announced by the United States for 2025 have introduced new variables that affect procurement strategies, supply chain resiliency, and cross-border collaboration in the cell isolation domain. Tariff activity has a cascading effect: increased import levies on instruments and specialized reagents heighten landed costs, which in turn requires laboratory procurement teams to re-evaluate purchase timing, vendor selection, and inventory strategies. Consequently, organizations are balancing short-term cost pressures with longer-term operational risks associated with substituting suppliers or switching to alternate technologies that may not yet be fully validated for their workflows.

In addition to price implications, tariffs influence supplier behavior and investment decisions. Some manufacturers respond by regionalizing production, diversifying component sourcing, or adjusting their distribution models to mitigate exposure. These adjustments can create transitional friction for customers who rely on consistent reagent lots and instrument part compatibility. Regulatory and customs delays, amplified by changed tariff classifications, also extend lead times and complicate just-in-time inventory approaches. To navigate this environment, organizations are increasingly prioritizing multi-sourcing strategies and establishing closer collaborations with vendors to secure supply continuity and maintain experimental reproducibility despite evolving trade policies.

Comprehensive segmentation-driven insights linking product categories, enabling technologies, cell types, and end-user priorities to inform procurement and development decisions

Understanding market dynamics requires clarity across multiple segmentation axes and the practical implications of each category for buyers and developers. From a product perspective, stakeholders differentiate among consumables, instruments, kits, and software and services; within consumables, disposables and reagents determine per-run economics and assay consistency, while data analysis software and maintenance services shape lifecycle value and uptime. Transitioning from product to technology, techniques such as centrifugation and filtration remain foundational for bulk separations, whereas flow cytometry, magnetic beads, and microfluidics support higher-resolution and targeted applications; the flow cytometry category itself divides between analytical cytometry and sorting cytometry, and magnetic bead technologies vary by scale from macro beads to nano beads, each offering trade-offs in binding kinetics and cell recovery.

Equally important is cell type segmentation, which directs technology choice: B cells, T cells, dendritic cells, stem cells, and cancer cells each impose distinct requirements for viability preservation, purity thresholds, and downstream compatibility. Application segmentation further refines priorities because cell therapy and stem cell research demand gentle, GMP-aligned workflows, while infectious disease and prenatal testing place premium value on speed, diagnostic sensitivity, and regulatory traceability. Finally, end-user segmentation highlights operational diversity: academic and research institutes prioritize experimental flexibility and cost-efficiency; biotech and pharma companies focus on scalability and regulatory alignment; contract research organizations emphasize throughput, reproducibility, and client reporting; and hospitals and clinics require clinical-grade reliability and integration with patient-care pathways. Together, these segmentation lenses create a nuanced map of requirements that innovators and purchasers must navigate when evaluating technologies and partnerships.

Regional dynamics and infrastructure considerations that influence the adoption pace, supplier strategies, and regulatory alignment across the Americas, EMEA, and Asia-Pacific

Regional dynamics impart distinct imperatives for technology adoption, supplier strategies, and regulatory alignment. In the Americas, investment in translational research and the growth of cell therapy manufacturing hubs drive demand for GMP-compatible instruments, validated consumables, and robust service models that support scale-up. Meanwhile, Europe, Middle East & Africa present a heterogeneous picture in which well-established research centers coexist with emerging clinical markets; here, regulatory nuance and reimbursement pathways shape adoption timelines, and partnerships with local distributors often determine market access and support quality.

Asia-Pacific continues to be a major locus of manufacturing capability and a rapidly expanding user base, characterized by aggressive capacity building, increasing domestic innovation, and growing domestic suppliers. This regional push frequently accelerates price competition and stimulates the development of localized service networks. Across all regions, harmonization of standards, the availability of trained personnel, and logistics infrastructure affect how quickly new separation technologies move from pilot use to routine deployment, making regional strategies central to commercial and operational planning.

How competitive positioning, platform integration, and evolving service models are shaping supplier strategies and creating differentiated value propositions in cell separation

Competitive activity among suppliers is increasingly defined by a mix of product innovation, platform integration, and commercial partnership models. Leading firms are expanding portfolios to couple instruments with proprietary consumables and software analytics to lock in long-term recurring revenue and improve user experience. Additionally, strategic alliances between instrument vendors and software developers accelerate end-to-end workflows that shorten the path from sample to insight. On the other hand, specialist providers continue to differentiate through niche offerings such as gentle isolation technologies for stem cells or high-speed sorters for oncology applications, preserving space for focused innovation alongside broader platform consolidation.

Service propositions are also evolving: maintenance contracts, remote diagnostics, and training programs have become essential elements of value, particularly for clinical and large-scale manufacturing customers who require predictable uptime. Mergers and acquisition activity, along with selective investments in application-specific R&D, reflect a marketplace where scale and depth of expertise both matter. For decision-makers, competitive positioning increasingly hinges on the ability to demonstrate validated workflows, regulatory support, and proven interoperability with downstream assays and data ecosystems.

Actionable pathways for leaders to strengthen supply resilience, accelerate validated technology adoption, and embed data interoperability for scalable cell separation workflows

Industry leaders should adopt a portfolio approach that balances near-term operational resilience with long-term innovation investments. First, prioritize multi-sourcing and inventory buffering to mitigate supply chain shocks and tariff-driven cost volatility, while negotiating contractual terms that preserve lot traceability and quality assurance. Second, invest in interoperable data platforms and validated analytics to enable cross-vendor integration and accelerate the translation of isolation outputs into downstream assays and manufacturing steps. These investments reduce friction during collaborations and support reproducible outcomes across distributed teams.

Concurrently, organizations should evaluate opportunities to pilot automation and microfluidic solutions for workflows that demand gentle handling or single-cell resolution, using staged validation plans to de-risk adoption. Building closer partnerships with suppliers to co-develop application-specific kits and service agreements can shorten validation cycles and improve total cost of ownership. Finally, commit to workforce development through targeted training programs that enhance operator proficiency and instrument uptime, and incorporate regulatory-readiness planning into early development milestones to streamline clinical translation and commercialization pathways.

A transparent, multi-source research methodology blending stakeholder interviews, technical literature review, and cross-validation to produce actionable and defensible insights

The research methodology underpinning this analysis combined a multi-pronged evidence base to ensure robust, reproducible conclusions. Primary inputs included structured interviews with laboratory directors, procurement specialists, instrument engineers, and clinical operations leaders to capture operational realities and adoption drivers across research and clinical settings. Secondary inputs encompassed public regulatory documents, peer-reviewed literature, and manufacturer technical specifications to validate performance claims and to understand regulatory constraints and validation requirements. These sources were synthesized to identify thematic trends, technology inflection points, and practical decision criteria used by end users.

Analytical rigor was maintained through cross-validation across data types, triangulation of qualitative insights with published technical benchmarks, and sensitivity checks to ensure conclusions remained consistent under varying operational assumptions. Emphasis was placed on transparency in assumptions and on documenting areas where data scarcity necessitated cautious interpretation, such as nascent microfluidic platforms or proprietary reagent formulations. This methodological approach supports actionable guidance while acknowledging the limits of available information and the dynamic nature of technological advancement.

Concluding synthesis of trends emphasizing interoperability, supply resilience, and workforce readiness as the critical enablers of scalable and reproducible cell isolation outcomes

In summary, cell isolation and separation continue to evolve through a combination of technological refinement, service-oriented commercial models, and regionally distinct adoption pathways. The most consequential trends are the shift toward data-integrated workflows, the maturation of gentle separation modalities for sensitive cell types, and the increasing importance of resilient supply chains in the face of tariff and logistics pressures. These forces collectively reshape procurement criteria, where end users now place comparable emphasis on lifecycle service, software interoperability, and regulatory compatibility as they do on raw instrument performance.

Looking ahead, organizations that prioritize interoperability, supplier collaboration, and workforce capability will be best positioned to translate isolation capabilities into downstream research and clinical value. While technology selection will remain contingent on cell type and application, the broader strategic emphasis is clear: align investments to enable reproducible, scalable workflows that integrate smoothly into analytical and manufacturing ecosystems, thereby accelerating scientific and therapeutic outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Cell Isolation/Cell Separation Market, by Product

  • 8.1. Consumables
    • 8.1.1. Disposables
    • 8.1.2. Reagents
  • 8.2. Instruments
  • 8.3. Kits
  • 8.4. Software And Services
    • 8.4.1. Data Analysis Software
    • 8.4.2. Maintenance Services

9. Cell Isolation/Cell Separation Market, by Technology

  • 9.1. Centrifugation
  • 9.2. Filtration
  • 9.3. Flow Cytometry
    • 9.3.1. Analytical Cytometry
    • 9.3.2. Sorting Cytometry
  • 9.4. Magnetic Beads
    • 9.4.1. Macro Beads
    • 9.4.2. Nano Beads
  • 9.5. Microfluidics

10. Cell Isolation/Cell Separation Market, by Cell Type

  • 10.1. B Cells
  • 10.2. Cancer Cells
  • 10.3. Dendritic Cells
  • 10.4. Stem Cells
  • 10.5. T Cells

11. Cell Isolation/Cell Separation Market, by Application

  • 11.1. Cell Therapy
  • 11.2. Immunology
  • 11.3. Infectious Diseases
  • 11.4. Oncology
  • 11.5. Prenatal Testing
  • 11.6. Stem Cell Research

12. Cell Isolation/Cell Separation Market, by End User

  • 12.1. Academic And Research Institutes
  • 12.2. Biotech And Pharma Companies
  • 12.3. Contract Research Organizations
  • 12.4. Hospitals And Clinics

13. Cell Isolation/Cell Separation Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Cell Isolation/Cell Separation Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Cell Isolation/Cell Separation Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Cell Isolation/Cell Separation Market

17. China Cell Isolation/Cell Separation Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Agilent Technologies, Inc
  • 18.6. Agilent Technologies, Inc.
  • 18.7. Beckman Coulter, Inc
  • 18.8. Beckman Coulter, Inc.
  • 18.9. Becton, Dickinson and Company
  • 18.10. Bio-Rad Laboratories, Inc
  • 18.11. Corning Incorporated
  • 18.12. Danaher Corporation
  • 18.13. GE Healthcare
  • 18.14. Lonza Group AG
  • 18.15. Merck KGaA
  • 18.16. Sartorius AG
  • 18.17. Terumo Corporation
  • 18.18. Thermo Fisher Scientific Inc

LIST OF FIGURES

  • FIGURE 1. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES CELL ISOLATION/CELL SEPARATION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA CELL ISOLATION/CELL SEPARATION MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY DISPOSABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY DISPOSABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY DISPOSABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY REAGENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAINTENANCE SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAINTENANCE SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAINTENANCE SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CENTRIFUGATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CENTRIFUGATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CENTRIFUGATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FILTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FILTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FILTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY ANALYTICAL CYTOMETRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY ANALYTICAL CYTOMETRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY ANALYTICAL CYTOMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SORTING CYTOMETRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SORTING CYTOMETRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SORTING CYTOMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MACRO BEADS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MACRO BEADS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MACRO BEADS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY NANO BEADS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY NANO BEADS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY NANO BEADS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MICROFLUIDICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MICROFLUIDICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY B CELLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY B CELLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY B CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CANCER CELLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CANCER CELLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CANCER CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY DENDRITIC CELLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY DENDRITIC CELLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY DENDRITIC CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY STEM CELLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY STEM CELLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY STEM CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY T CELLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY T CELLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY T CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY IMMUNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY IMMUNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRENATAL TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRENATAL TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRENATAL TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY STEM CELL RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY STEM CELL RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY BIOTECH AND PHARMA COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY BIOTECH AND PHARMA COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY BIOTECH AND PHARMA COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. GCC CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 200. GCC CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 201. GCC CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 202. GCC CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
  • TABLE 203. GCC CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 204. GCC CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 205. GCC CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2018-2032 (USD MILLION)
  • TABLE 206. GCC CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. GCC CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 208. GCC CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPEAN UNION CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 224. BRICS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. BRICS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 229. G7 CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 230. G7 CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 231. G7 CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 232. G7 CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
  • TABLE 233. G7 CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 234. G7 CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 235. G7 CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2018-2032 (USD MILLION)
  • TABLE 236. G7 CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. G7 CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 238. G7 CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 239. NATO CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 240. NATO CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 241. NATO CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 242. NATO CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
  • TABLE 243. NATO CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 244. NATO CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 245. NATO CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2018-2032 (USD MILLION)
  • TABLE 246. NATO CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. NATO CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 248. NATO CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 249. GLOBAL CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES CELL ISOLATION/CELL SEPARATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 252. UNITED STATES CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED STATES CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
  • TABLE 254. UNITED STATES CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 255. UNITED STATES CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. UNITED STATES CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 260. CHINA CELL ISOLATION/CELL SEPARATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 261. CHINA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 262. CHINA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 263. CHINA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
  • TABLE 264. CHINA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 265. CHINA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY FLOW CYTOMETRY, 2018-2032 (USD MILLION)
  • TABLE 266. CHINA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY MAGNETIC BEADS, 2018-2032 (USD MILLION)
  • TABLE 267. CHINA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 268. CHINA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 269. CHINA CELL ISOLATION/CELL SEPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)